drugset
drugset / Trial / NCT02967432

Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU

NCT02967432 ↗

Phase 2 Completed 216 enrolled Crouse Hospital Dale Franz, RPh · collabDavid Martin, RN · collabJana Shaw, MD · collabRachel Carey · collabSteven Gross, MD · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether or not mupirocin treatment results in S. aureus decolonization in affected NICU patients.

Timeline

Start
2016-10
Primary completion
2019-12
Completion
2019-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mupirocin Small molecule — Topical

Indications

staphylococcal infection